India's health biotech sector at a crossroads

  title={India's health biotech sector at a crossroads},
  author={Sarah E Frew and Rahim Rezaie and Stephen M. Sammut and Monali Ray and Abdallah S. Daar and Peter A. Singer},
  journal={Nature Biotechnology},
Indian biotech is at a crossroads. It must not only address the significant health needs of its domestic population, but also position itself to take advantage of the often more profitable global marketplace. The country’s health biotech companies operate in close proximity to the shocking disparities in health that plague our globe today. Although these firms are uniquely suited to address these needs, they require financial and political support before they will commit to doing so. In earlier… CONTINUE READING